Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by mkprovoson Jun 25, 2010 2:49pm
534 Views
Post# 17222712

The way I see it

The way I see it

We have $1.4 million left at the end of the year, $640,000 in long term debt.  That leaves $800,000 for us to share.  That is about 1/2 a cent for each share. 

I will wait until the day it ends and hope to collect my
.005, plus anythign we can get for the patents.

If we go to phase III I win.   I love gambling 

Bullboard Posts